A Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed(DTcP)

Clinical trial NCT05951725 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05951725
Sponsor: CanSino Biologics Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Diphtheria, Tetanus and Acellular Pertussis

Start date: 2023-08-11
Primary completion: 2025-04-01
Enrollment: 2520

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.